Clinical considerations in the management of asymptomatic carotid artery stenosis

Philipp Taussky1, Ricardo A Hanel, Fredric B Meyer

  • 1Department of Neurosurgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

Neurosurgical Focus
|December 3, 2011
PubMed

Insights

Asymptomatic internal carotid artery stenosis management is complex. This review covers natural history, diagnosis, and treatment options, including carotid endarterectomy and angioplasty with stenting, to aid patient counseling.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiology

Background:

  • Asymptomatic internal carotid artery stenosis (ICAS) diagnosis is increasing due to an aging population.
  • Managing ICAS presents challenges for physicians and patients.
  • Evidence-based guidelines for ICAS treatment have evolved with new trial data.

Purpose of the Study:

  • To review the natural history, diagnosis, and treatment of asymptomatic internal carotid artery stenosis.
  • To provide guidance for counseling patients on management options.
  • To synthesize data from randomized controlled trials, including CREST.

Main Methods:

  • Literature review of natural history, diagnosis, and treatment strategies for ICAS.
  • Analysis of data from large randomized controlled trials comparing interventions.
  • Focus on evidence-based approaches for patient risk stratification.

Main Results:

  • Consensus on ICAS treatment was lacking before major trials.
  • Carotid artery angioplasty and stenting (CAS) emerged as an alternative to carotid endarterectomy (CEA).
  • The CREST trial compared CEA and CAS in symptomatic and asymptomatic patients.

Conclusions:

  • Optimal management of asymptomatic ICAS requires individualized risk assessment.
  • Understanding evidence from trials like CREST is crucial for informed patient counseling.
  • This review consolidates current knowledge to support clinical decision-making for ICAS.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...